Alissa R. Segal, PharmD, RPh, CDCES, CDTC is a Professor of Pharmacy Practice at the Massachusetts College of Pharmacy & Health Sciences and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing her post-doctorate residencies, Dr. Segal spent several years teaching at the University of New Mexico, where she also cared for patients and completed scholarly work in family practice. In 2007, Dr. Segal joined MCPHS and established clinical pharmacy services at the Joslin Diabetes Center. Her research focus is on the care of adults with diabetes and has led to numerous publications. She also serves on the ADA’s Primary Care Advisory Group and Professional Practice Committees and is a fellow of the American College of Clinical Pharmacy.

Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.

Richard Pratley, MD serves as the Samuel E. Crockett Chair in Diabetes Research, Senior Investigator and Diabetes Program Lead at the AdventHealth Translational Research Institute, and Medical Director at the AdventHealth Diabetes Institute, in Orlando, Florida, and is an Adjunct Professor of Medicine at the Johns Hopkins University School of Medicine. Dr. Pratley has published over 300 peer-reviewed articles on diabetes and its complications. He has served as a member of various editorial boards and is an ad hoc reviewer for many journals. He received his MD from Wayne State University and completed fellowships in geriatric medicine and gerontology at the University of Michigan, Johns Hopkins University, and the National Institute on Aging.

Eugene E. Wright, Jr., MD, graduated from Duke University School of Medicine, Durham, NC, and currently works for South Piedmont AHEC as well as serves as Consulting Associate for the university’s Department of Medicine. He serves as an Associate Editor for the Clinical Diabetes medical journal in addition to several other advisory and editorial boards. Dr. Wright is the inaugural chair of the ADA’s Primary Care Interest Group, a member of the ADA/AHA Know Diabetes by Heart initiative, and a member of the planning committee for the ADA’s annual Clinical Update Conference. He has published several articles on diabetes diagnosis, treatment and management and has given presentations at national and international meetings on new treatments and technology for diabetes.

Robert C. Stanton, M.D., is Chief of the Kidney and Hypertension Section at the Joslin Diabetes Center and an Associate Professor of Medicine at Harvard Medical School, Boston, MA. His research has focused on the essential enzyme G6PD and how its dysregulation affects the pathogenesis of many diabetic- and kidney-related diseases. Dr. Stanton serves on the Professional Practice Committee of the American Diabetes Association and is the Chair of the Chronic Kidney Guidelines Section. He is also the recipient of three honorary professorships as well as a lifetime achievement teaching award for Sustained Excellence in Teaching from Harvard Medical School.

Katherine R. Tuttle, MD, FASN, FACP, FNKF, is Executive Director for Research at Providence Inland Northwest Health, Regional Principal Investigator of the Institute of Translational Health Sciences, and Professor of Medicine at the University of Washington. Dr. Tuttle earned her medical degree from Northwestern University in Chicago, IL. Her major research interests are in diabetes and chronic kidney disease, and she has published over 300 original peer-reviewed articles. Dr. Tuttle also serves as chair of the Diabetic Kidney Disease Collaborative for the American Society of Nephrology. She has received many honors and awards including the Medal of Excellence from the American Association of Kidney Patients and the Garabed Eknoyan Award from the National Kidney Foundation.